NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Quantitative expression of activation markers on defined CD4 and CD8 lymphocyte subsets correlates with viral suppression/relapse status of HIV-1+ patients receiving HAART.

Ottinger JS, Gryszowka VE, Huggins JM, Wellons MF, Bartlett JA, Weinhold KJ; Conference on Retroviruses and Opportunistic Infections.

Program Abstr 8th Conf Retrovir Oppor Infect Conf Retrovir Oppor Infect 8th 2001 Chic Ill. 2001 Feb 4-8; 8: 153 (abstract no. 369).

Duke Univ Med Ctr, Durham, NC.

Background; Quantitative changes in markers of cellular activation, such as CD38 and CD95, have been associated with AIDS pathogenesis and disease progression. In this cross-sectional study, expression of the activation markers CD38 and CD95, as well as the chemokine receptors CXCR4 and CCR5, was quantitated on defined CD4+ and CD8+ lymphocyte subsets. Methods: Fresh whole- blood specimens were obtained from uninfected volunteers and HAART-treated HIV-1+ patients categorized as 'stable suppressed' (SS), 'low viral relapse' (LVR), or 'high viral relapse' (HVR). The CD4+ and CD8+ lymphocyte subsets were defined as naive (CD62L+ CD45RA+), memory (CD62L+ CD45RA-, CD62L- CD45RA-, CD62L- CD45RA+), and activated (CD38+ HLA- DR+). Results: CD38 antibodies bound per cell (ABC) increased across all groups for all subsets of CD4+ as well as total and memory CD8+ lymphocytes. Among CD4+ lymphocytes, CD38 ABC was greater on the naive subset, while naive and activated CD4+ cells expressed the most CD38 ABC, irrespective of study group. In contrast, the naive to memory ratio of CD38 ABC on CD8+ subsets decreased across all groups. CD95 ABC increased significantly between the SS and LVR groups for CD4+ and CD8+ total and memory subsets, as well as the naive CD4+ lymphocytes. In addition, CD95 ABC was more significant in the CD4+ subset compared to the CD8+ subset. Within CD4+ cells, CD95 ABC was more profound in the naive subset. For CXCR4 and CCR5, no differences were observed across groups for either CD4+ or CD8+ lymphocyte subsets. Conclusion: In conclusion, quantitative expression of CD38, and perhaps CD95, on naive CD4 subsets may represent a significant immunologic parameter for predicting viral relapse on HAART.

Publication Types:
  • Meeting Abstracts
Keywords:
  • ADP-ribosyl Cyclase
  • Acquired Immunodeficiency Syndrome
  • Antigens, CD
  • Antigens, CD4
  • Antigens, CD45
  • Antigens, CD8
  • Antigens, CD95
  • Antiretroviral Therapy, Highly Active
  • Biological Markers
  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes
  • Cross-Sectional Studies
  • HIV-1
  • Humans
  • Lymphocyte Count
  • Lymphocyte Subsets
  • Receptors, CCR5
  • Receptors, CXCR4
  • immunology
  • virology
Other ID:
  • GWAIDS0006656
UI: 102244152

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov